The World Health Organization (WHO) has approved the COVID-19 vaccine developed by Chinese drug manufacturer Sinovac Biotech for emergency use listing.
It’s the second Chinese brand of CoVID-19 vaccine to get the UN health agency endorsement after Sinopharm.
RELATED STORY: WHO grants emergency use approval for Sinopharm vaccine
A WHO emergency listing is a signal to national regulators on a product’s safety and efficacy.
In a statement, WHO said its Strategic Advisory Group of Experts on Immunization (SAGE) recommended Sinovac jabs for adults over 18, with a second dose 2-4 weeks later.
READ ON: WHO grants emergency use listing for Moderna’s COVID-19 vaccine
The listing of Sinovac doses to UN health agency’s EUL will allow the vaccine sharing facility COVAX and other organizations to distribute the vaccines to developing countries.
The Chinese drugmaker said it has supplied more than 600 million doses as of the end of May with over 430 million doses have been administered. (RA)
